Welcome to our dedicated page for Sylvamo SEC filings (Ticker: SLVM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sylvamo Corporation filings document the reporting framework for a public uncoated papers company listed on the New York Stock Exchange under SLVM. Form 8-K reports include operating and financial results, material agreements, capital-structure disclosures, board changes, executive appointments and other material events.
The company’s proxy materials cover annual shareowner voting, director elections, auditor ratification, executive compensation and board governance. Recent filings also document common stock, preferred stock purchase rights, rights-agreement mechanics, governance arrangements and disclosure controls related to Sylvamo’s paper mills and regional operating model.
Sylvamo Corp senior executive Shawn Lawson reported a routine tax-withholding transaction related to restricted stock units (RSUs). On the event date, 979.9723 shares of common stock were withheld at a deemed price of $39.27 per share to cover taxes triggered by RSU vesting. This disposition was not an open-market sale but a payment of tax liability in shares, which is described as exempt under Rule 16b-3(e). After the withholding, Lawson directly held 16,675.6582 shares of Sylvamo common stock.
Sylvamo Corp executive Kevin W. Ferguson, VP, Controller and Chief Accounting Officer, had 204.0278 shares of common stock withheld at a deemed price of $39.27 per share to cover taxes on vesting restricted stock units (RSUs). This is a tax-withholding disposition, not an open-market sale. After the withholding, Ferguson directly holds 6,052.9248 shares of Sylvamo common stock.
Sylvamo Corp reported an insider transaction for SVP Chief Financial Officer Donald P. Devlin involving restricted stock unit vesting. On the transaction date, 812.6736 shares of common stock were withheld to cover tax obligations, valued at $39.27 per share. This was a tax-withholding disposition, not an open-market trade, and was exempt under Rule 16b-3(e). After the withholding, Devlin directly owns 28,174.4975 shares of Sylvamo common stock.
Sylvamo Corp director David D. Petratis corrected a prior insider report to show a grant of 10,207 share units. The amended Form 4 states the award represents 3,876 time-based restricted stock units and 6,331 RSUs taken instead of a cash retainer for board service.
The RSUs convert one-for-one into common stock on the earlier of May 13, 2027, or the next annual shareowners meeting, with settlement deferred until May 13, 2032, or when his board service ends. Following this award, he is reported as holding 37,690 common shares directly.
Sylvamo Corporation reported the results of its annual shareholder meeting, where all proposals received shareholder support. Stockholders elected seven directors, with support for individual nominees generally around 29–31 million votes, and John V. Sims receiving 30,802,802 votes in favor.
Shareholders also ratified Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 33,393,461 votes for. In addition, stockholders approved, on a non-binding advisory basis, the compensation of the company’s named executive officers, with 30,295,547 votes in favor.
Zallie James P. reported acquisition or exercise transactions in this Form 4 filing.
Sylvamo Corp director James P. Zallie received an equity grant of 3,876 shares of common stock in the form of restricted stock units. The RSUs were granted for service as a director for the 2026-2027 performance year at a reference price of $38.70 per share.
The RSUs will vest and settle one-for-one in common stock on the earlier of May 13, 2027, or the next annual shareowners meeting. After this award, Zallie holds a total of 16,705 shares of Sylvamo common stock directly.
Sylvamo Corp director David D. Petratis received an equity award rather than buying shares on the market. He was granted 7,623 common-share–equivalent restricted stock units at a reference price of $38.70 per share, increasing his direct holdings to 35,106 shares. The grant covers service for the 2026-2027 performance year. The award consists of 3,876 time-based RSUs and 3,747 RSUs taken in lieu of a cash retainer, which will convert one-for-one into common stock on the earlier of May 13, 2027, or the next annual shareowners meeting. Settlement of the vested RSUs is deferred until the earlier of May 13, 2032, or the end of his board service.
JOHNSON JOIA M reported acquisition or exercise transactions in this Form 4 filing.
Sylvamo Corp director Joia M. Johnson reported a grant of 3,876 shares of common stock in the form of time-based restricted stock units (RSUs). These RSUs were awarded for service as a director for the 2026-2027 performance year and will vest upon the earlier of May 13, 2027, or the next annual shareowners meeting. Following this award, Johnson directly holds 16,705 shares of Sylvamo common stock. This is a compensation-related equity grant, not an open-market purchase.
Desmond Jeanmarie F. reported acquisition or exercise transactions in this Form 4 filing.
Sylvamo Corp director Desmond Jeanmarie F. received a grant of 3,876 shares of Common Stock in the form of time-based restricted stock units as compensation for board service for the 2026-2027 performance year. These RSUs were valued at $38.70 per share for reporting purposes.
The RSUs will vest upon the earlier of May 13, 2027, or the next annual shareowners meeting. The director has elected to defer settlement of any vested RSUs until the first to occur of May 13, 2032, or the end of her service as a director. After this award, she directly holds 16,734 shares of Sylvamo stock.
Bruce Lizanne M reported acquisition or exercise transactions in this Form 4 filing.
Sylvamo Corp director Lizanne M. Bruce reported receiving an equity grant of 3,876 shares of Common Stock in the form of time-based restricted stock units (RSUs). The RSUs were granted for service as a director for the 2026-2027 performance year at a referenced value of $38.70 per share.
The RSUs will vest and settle one-for-one in common stock upon the earlier of May 13, 2027, or the next annual shareowners meeting. Following this grant, Bruce’s directly held Common Stock position reported in this filing is 15,705 shares. This is a routine, compensation-related award rather than an open-market purchase.